SILO PHARMA, INC. (SILO) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Win.
12/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 5 wins, 7 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseSILO / S&P 15.00% / 15.20% |
LoseSILO / S&P SILO unavailable / 15.00% |
LoseSILO / S&P -73.26% / 50.40% |
| 2026-Q12/3 |
WinSILO / S&P 5.88% / -4.33% |
LoseSILO / S&P 0.00% / 11.30% |
WinSILO / S&P 166.67% / 27.70% |
| 2025-Q41/3 |
LoseSILO / S&P -50.72% / 2.65% |
LoseSILO / S&P 0.00% / 9.00% |
WinSILO / S&P 164.75% / 13.40% |
| 2025-Q32/3 |
WinSILO / S&P 9.52% / 8.12% |
LoseSILO / S&P 0.00% / 4.61% |
WinSILO / S&P 205.88% / 13.45% |
| 2025-Q21/3 |
LoseSILO / S&P -46.15% / 10.94% |
LoseSILO / S&P 0.00% / 4.83% |
WinSILO / S&P 216.95% / 10.63% |
| 2025-Q11/3 |
WinSILO / S&P 31.46% / -4.27% |
LoseSILO / S&P 0.00% / 4.98% |
LoseSILO / S&P -1.68% / 10.57% |
| 2024-Q40/3 |
LoseSILO / S&P -19.09% / 2.41% |
LoseSILO / S&P 0.00% / 5.25% |
LoseSILO / S&P 1.67% / 6.15% |
| 2024-Q31/3 |
WinSILO / S&P 10.00% / 5.89% |
LoseSILO / S&P 0.00% / 5.89% |
LoseSILO / S&P SILO unavailable / 6.11% |
| 2024-Q20/3 |
LoseSILO / S&P -48.72% / 4.28% |
LoseSILO / S&P 0.00% / 5.38% |
LoseSILO / S&P SILO unavailable / 5.12% |
| 2024-Q11/3 |
WinSILO / S&P 35.42% / 10.56% |
LoseSILO / S&P 0.00% / 5.71% |
LoseSILO / S&P SILO unavailable / 5.59% |
| 2023-Q40/3 |
LoseSILO / S&P -13.77% / 11.69% |
LoseSILO / S&P SILO unavailable / 6.81% |
LoseSILO / S&P SILO unavailable / 7.78% |
| 2023-Q30/3 |
LoseSILO / S&P -18.54% / -3.27% |
LoseSILO / S&P SILO unavailable / 7.52% |
LoseSILO / S&P SILO unavailable / -5.03% |
| 2023-Q20/3 |
LoseSILO / S&P -2.38% / 8.74% |
LoseSILO / S&P SILO unavailable / 9.50% |
LoseSILO / S&P SILO unavailable / -8.57% |
| 2023-Q10/3 |
LoseSILO / S&P -37.50% / 7.50% |
LoseSILO / S&P SILO unavailable / 10.77% |
LoseSILO / S&P SILO unavailable / -15.69% |
| 2022-Q40/3 |
LoseSILO / S&P -37.55% / 7.56% |
LoseSILO / S&P SILO unavailable / 11.88% |
LoseSILO / S&P SILO unavailable / -17.99% |
| 2022-Q31/3 |
WinSILO / S&P -2.18% / -4.88% |
LoseSILO / S&P SILO unavailable / 13.47% |
LoseSILO / S&P SILO unavailable / -1.41% |
| 2022-Q20/3 |
LoseSILO / S&P -47.62% / -16.10% |
LoseSILO / S&P SILO unavailable / 13.71% |
LoseSILO / S&P SILO unavailable / 11.04% |
| 2022-Q11/3 |
WinSILO / S&P 46.85% / -4.60% |
LoseSILO / S&P SILO unavailable / 15.97% |
LoseSILO / S&P SILO unavailable / 42.23% |
| 2021-Q40/3 |
LoseSILO / S&P -26.67% / 11.03% |
LoseSILO / S&P SILO unavailable / 15.00% |
LoseSILO / S&P SILO unavailable / 96.40% |
| 2021-Q30/3 |
LoseSILO / S&P -22.00% / 0.58% |
LoseSILO / S&P SILO unavailable / 10.77% |
LoseSILO / S&P SILO unavailable / 69.42% |
| 2021-Q21/3 |
LoseSILO / S&P -13.79% / 8.55% |
WinSILO / S&P 257.32% / 6.58% |
LoseSILO / S&P SILO unavailable / 51.81% |
| 2021-Q10/3 |
LoseSILO / S&P SILO unavailable / 6.17% |
LoseSILO / S&P SILO unavailable / -1.06% |
LoseSILO / S&P SILO unavailable / 7.39% |
| 2020-Q40/3 |
LoseSILO / S&P SILO unavailable / 12.15% |
LoseSILO / S&P SILO unavailable / -3.72% |
LoseSILO / S&P SILO unavailable / -33.42% |
| 2020-Q30/3 |
LoseSILO / S&P SILO unavailable / 8.93% |
LoseSILO / S&P SILO unavailable / -2.04% |
LoseSILO / S&P SILO unavailable / -27.10% |
| 2020-Q20/3 |
LoseSILO / S&P SILO unavailable / 20.54% |
LoseSILO / S&P SILO unavailable / -0.46% |
LoseSILO / S&P SILO unavailable / -27.11% |
| 2020-Q10/3 |
LoseSILO / S&P SILO unavailable / -19.60% |
LoseSILO / S&P SILO unavailable / 3.47% |
LoseSILO / S&P SILO unavailable / -14.75% |
| 2019-Q40/3 |
LoseSILO / S&P SILO unavailable / 9.07% |
LoseSILO / S&P SILO unavailable / 5.36% |
LoseSILO / S&P SILO unavailable / 2.99% |
| 2019-Q30/3 |
LoseSILO / S&P SILO unavailable / 1.70% |
LoseSILO / S&P SILO unavailable / 5.02% |
LoseSILO / S&P SILO unavailable / 0.21% |
| 2019-Q20/3 |
LoseSILO / S&P SILO unavailable / 4.30% |
LoseSILO / S&P SILO unavailable / 6.64% |
LoseSILO / S&P SILO unavailable / 8.65% |
| 2019-Q10/3 |
LoseSILO / S&P SILO unavailable / 13.65% |
LoseSILO / S&P SILO unavailable / 8.12% |
LoseSILO / S&P SILO unavailable / 14.29% |
| 2018-Q40/3 |
LoseSILO / S&P SILO unavailable / -13.52% |
LoseSILO / S&P SILO unavailable / 9.05% |
LoseSILO / S&P SILO unavailable / 18.23% |
| 2018-Q30/3 |
LoseSILO / S&P SILO unavailable / 7.71% |
LoseSILO / S&P SILO unavailable / 10.21% |
LoseSILO / S&P SILO unavailable / 19.06% |
| 2018-Q20/3 |
LoseSILO / S&P SILO unavailable / 3.43% |
LoseSILO / S&P SILO unavailable / 9.03% |
LoseSILO / S&P SILO unavailable / 14.46% |
| 2018-Q10/3 |
LoseSILO / S&P SILO unavailable / -0.76% |
LoseSILO / S&P SILO unavailable / 7.68% |
LoseSILO / S&P SILO unavailable / 12.46% |
| 2017-Q40/3 |
LoseSILO / S&P SILO unavailable / 6.64% |
LoseSILO / S&P SILO unavailable / 7.03% |
LoseSILO / S&P SILO unavailable / 13.82% |
| 2017-Q30/3 |
LoseSILO / S&P SILO unavailable / 4.48% |
LoseSILO / S&P SILO unavailable / 5.68% |
LoseSILO / S&P SILO unavailable / 17.57% |
| 2017-Q20/3 |
LoseSILO / S&P SILO unavailable / 3.09% |
LoseSILO / S&P SILO unavailable / 4.83% |
LoseSILO / S&P SILO unavailable / 17.74% |
| 2017-Q10/3 |
LoseSILO / S&P SILO unavailable / 6.07% |
LoseSILO / S&P SILO unavailable / 3.67% |
LoseSILO / S&P SILO unavailable / 13.32% |
| 2016-Q40/3 |
LoseSILO / S&P SILO unavailable / 3.82% |
LoseSILO / S&P SILO unavailable / 2.09% |
LoseSILO / S&P SILO unavailable / 7.05% |
| 2016-Q30/3 |
LoseSILO / S&P SILO unavailable / 3.85% |
LoseSILO / S&P SILO unavailable / 0.20% |
LoseSILO / S&P SILO unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SILO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -73.04% | 20.78% |
| Annualized return | -73.04% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SILO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -97.97% | 83.14% |
| Annualized return | -54.14% | 12.86% |
10Y · 2021-01-08 to 2026-08-27
| Metric | SILO total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.03% | 319.30% |
| Annualized return | -37.11% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |